Category: Business & Technology
-
Kestrel Biologics Hits Its Hiring Target, With Help It Didn’t Expect to Need
Kestrel Biologics says it has nearly doubled its Bellwater workforce, hitting its two-year hiring target partly by absorbing technicians laid off by rival Ridgeline Therapeutics.
-
After Twenty Years on Vale Avenue, the Millhouse Café Is Betting on Foundry Row
Vale Avenue’s Millhouse Café will open a second location near Foundry Row this fall, betting that the neighborhood’s growing biotech workforce can support a satellite of the downtown institution.
-
Bellwater Turbine Works Lands Its First Overseas Buyer
Bellwater Turbine Works will begin shipping turbine components to a Canadian wind developer this fall under its first export contract, though the $22 million deal depends on solving a persistent hiring gap.
-
A Kincaid Research Project Becomes Forge Bellwater’s First AI Startup
A Kincaid University research project has become Forge Bellwater’s first AI-focused startup, expanding the kind of company the biotech-heavy Foundry Row incubator has historically supported.
-
Biotech Jobs on Foundry Row Have Doubled in Five Years, City-Commissioned Report Finds
A new city-commissioned report finds Foundry Row’s biotech cluster has roughly doubled its workforce in five years, though hiring growth has slowed amid a persistent shortage of trained technicians.
-
Kestrel Biologics Weighs West Bellwater for New Manufacturing Site
Kestrel Biologics is scouting sites for a second manufacturing facility, including in West Bellwater, as the Foundry Row biotech firm outgrows its current lab and production space.
-
Gene-Therapy Trial Clears Early Safety Hurdle for Kestrel Biologics
Kestrel Biologics says its lead gene-therapy candidate has cleared an early safety milestone in its Phase 1 trial, a result executives call validation for the Foundry Row biotech firm’s $64 million funding round.
-
With Office Towers Half Empty, Downtown Bellwater Looks to Housing
With downtown office vacancy above 23 percent, developers have proposed converting two Vale Avenue towers into apartments, setting up a fight over tax abatements and affordability requirements.
-
How Ledger & Leaf Books Outlasted Two Recessions and a Pandemic on Vale Avenue
Vale Avenue’s Ledger & Leaf Books turns twenty this weekend, having outlasted chain bookstores and online retail even as rising downtown rents and a changing customer base test its next chapter.
-
Ridgeline Therapeutics Closes $38 Million Round to Compete for Biotech Talent
Ridgeline Therapeutics has closed a $38 million funding round it says is aimed at competing with rival Kestrel Biologics for Bellwater’s limited pool of biotech talent.